67 related articles for article (PubMed ID: 19445670)
1. siRNA-based targeting of antiapoptotic genes can reverse chemoresistance in P-glycoprotein expressing chondrosarcoma cells.
Kim DW; Kim KO; Shin MJ; Ha JH; Seo SW; Yang J; Lee FY
Mol Cancer; 2009 May; 8():28. PubMed ID: 19445670
[TBL] [Abstract][Full Text] [Related]
2. Glutamine metabolism controls amphiregulin-facilitated chemoresistance to cisplatin in human chondrosarcoma.
Wu YY; Law YY; Huang YW; Tran NB; Lin CY; Lai CY; Huang YL; Tsai CH; Ko CY; Chou MC; Huang WC; Cheng FJ; Fong YC; Tang CH
Int J Biol Sci; 2023; 19(16):5174-5186. PubMed ID: 37928274
[TBL] [Abstract][Full Text] [Related]
3. Integrated molecular characterization of chondrosarcoma reveals critical determinants of disease progression.
Nicolle R; Ayadi M; Gomez-Brouchet A; Armenoult L; Banneau G; Elarouci N; Tallegas M; Decouvelaere AV; Aubert S; Rédini F; Marie B; Labit-Bouvier C; Reina N; Karanian M; le Nail LR; Anract P; Gouin F; Larousserie F; de Reyniès A; de Pinieux G
Nat Commun; 2019 Oct; 10(1):4622. PubMed ID: 31604924
[TBL] [Abstract][Full Text] [Related]
4. Hunting for the vulnerability in chondrosarcoma by tracing metabolic and genetic links.
Kim YJ; Kang HG; Kim JH
Cell Rep Med; 2024 Jan; 5(1):101385. PubMed ID: 38232691
[TBL] [Abstract][Full Text] [Related]
5.
Wang N; Zhang L; Leng XX; Xie YL; Kang ZR; Zhao LC; Song LH; Zhou CB; Fang JY
Gut Microbes; 2024; 16(1):2333790. PubMed ID: 38533566
[TBL] [Abstract][Full Text] [Related]
6. BCL-2 protein family: attractive targets for cancer therapy.
Kaloni D; Diepstraten ST; Strasser A; Kelly GL
Apoptosis; 2023 Feb; 28(1-2):20-38. PubMed ID: 36342579
[TBL] [Abstract][Full Text] [Related]
7. Proximal humerus chondrosarcoma in a young male patient.
Ene R; Cîrstoiu FC; Nica M; Pánti ZA; Panaitescu C; Popescu E; Dumitru AV; Eremia IA; Cursaru A; Ene D
Rom J Morphol Embryol; 2020; 61(3):917-922. PubMed ID: 33817734
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Anti-Apoptotic Bcl-2 Proteins in Preclinical and Clinical Studies: Current Overview in Cancer.
D'Aguanno S; Del Bufalo D
Cells; 2020 May; 9(5):. PubMed ID: 32455818
[TBL] [Abstract][Full Text] [Related]
9. Doxorubicin-conjugated dexamethasone induced MCF-7 apoptosis without entering the nucleus and able to overcome MDR-1-induced resistance.
Chaikomon K; Chattong S; Chaiya T; Tiwawech D; Sritana-Anant Y; Sereemaspun A; Manotham K
Drug Des Devel Ther; 2018; 12():2361-2369. PubMed ID: 30122894
[TBL] [Abstract][Full Text] [Related]
10. Real-time monitoring of cisplatin cytotoxicity on three-dimensional spheroid tumor cells.
Baek N; Seo OW; Lee J; Hulme J; An SS
Drug Des Devel Ther; 2016; 10():2155-65. PubMed ID: 27445462
[TBL] [Abstract][Full Text] [Related]
11. miR-125b acts as a tumor suppressor in chondrosarcoma cells by the sensitization to doxorubicin through direct targeting the ErbB2-regulated glucose metabolism.
Tang XY; Zheng W; Ding M; Guo KJ; Yuan F; Feng H; Deng B; Sun W; Hou Y; Gao L
Drug Des Devel Ther; 2016; 10():571-83. PubMed ID: 26966351
[TBL] [Abstract][Full Text] [Related]
12. An orthotopic mouse model for chondrosarcoma of bone provides an in vivo tool for drug testing.
van Oosterwijk JG; Plass JR; Meijer D; Que I; Karperien M; Bovée JV
Virchows Arch; 2015 Jan; 466(1):101-9. PubMed ID: 25331842
[TBL] [Abstract][Full Text] [Related]
13. Lysosomal drug sequestration as a mechanism of drug resistance in vascular sarcoma cells marked by high CSF-1R expression.
Gorden BH; Saha J; Khammanivong A; Schwartz GK; Dickerson EB
Vasc Cell; 2014; 6():20. PubMed ID: 25295160
[TBL] [Abstract][Full Text] [Related]
14. GDC-0449 in patients with advanced chondrosarcomas: a French Sarcoma Group/US and French National Cancer Institute Single-Arm Phase II Collaborative Study.
Italiano A; Le Cesne A; Bellera C; Piperno-Neumann S; Duffaud F; Penel N; Cassier P; Domont J; Takebe N; Kind M; Coindre JM; Blay JY; Bui B
Ann Oncol; 2013 Nov; 24(11):2922-6. PubMed ID: 24170610
[TBL] [Abstract][Full Text] [Related]
15. rAAV Vectors as Safe and Efficient Tools for the Stable Delivery of Genes to Primary Human Chondrosarcoma Cells In Vitro and In Situ.
Madry H; Venkatesan JK; Schmitt G; Schetting S; Ekici M; Kohn D; Cucchiarini M
Sarcoma; 2012; 2012():347417. PubMed ID: 22645415
[TBL] [Abstract][Full Text] [Related]
16. Cyclosporine A enables vincristine-induced apoptosis during reversal of multidrug resistance phenotype in chronic myeloid leukemia cells.
de Souza PS; da Cunha Vasconcelos F; Silva LF; Maia RC
Tumour Biol; 2012 Aug; 33(4):943-56. PubMed ID: 22290425
[TBL] [Abstract][Full Text] [Related]
17. The antiapoptotic gene survivin is highly expressed in human chondrosarcoma and promotes drug resistance in chondrosarcoma cells in vitro.
Lechler P; Renkawitz T; Campean V; Balakrishnan S; Tingart M; Grifka J; Schaumburger J
BMC Cancer; 2011 Apr; 11():120. PubMed ID: 21457573
[TBL] [Abstract][Full Text] [Related]
18. HtrA1 sensitizes ovarian cancer cells to cisplatin-induced cytotoxicity by targeting XIAP for degradation.
He X; Khurana A; Maguire JL; Chien J; Shridhar V
Int J Cancer; 2012 Mar; 130(5):1029-35. PubMed ID: 21387310
[TBL] [Abstract][Full Text] [Related]
19. Surmounting chemotherapy and radioresistance in chondrosarcoma: molecular mechanisms and therapeutic targets.
Onishi AC; Hincker AM; Lee FY
Sarcoma; 2011; 2011():381564. PubMed ID: 21234363
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic molecular targets in human chondrosarcoma.
Jamil N; Howie S; Salter DM
Int J Exp Pathol; 2010 Oct; 91(5):387-93. PubMed ID: 21078112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
